[{"address1": "2701 Eastlake Avenue East", "city": "Seattle", "state": "WA", "zip": "98102", "country": "United States", "phone": "206 333 2001", "website": "https://www.nautilus.bio", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.", "fullTimeEmployees": 164, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sujal M. Patel", "age": 48, "title": "Co-Founder, CEO, President, Secretary & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 827240, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Parag  Mallick Ph.D.", "age": 45, "title": "Co-Founder, Chief Scientist & Director", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 562800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anna  Mowry", "age": 39, "title": "CFO & Treasurer", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 519212, "exercisedValue": 0, "unexercisedValue": 591747}, {"maxAge": 1, "name": "Ms. Mary E. Godwin", "age": 64, "title": "Senior Vice President of Operations", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew B. Murphy ESQ.", "age": 58, "title": "General Counsel", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 382645, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chris  Blessington", "title": "Vice President of Corporate Marketing & Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gwen E. Weld", "age": 65, "title": "Chief People Officer", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 390968, "exercisedValue": 0, "unexercisedValue": 2993}, {"maxAge": 1, "name": "Mr. Nick A. Nelson", "age": 39, "title": "Chief Business Officer & Senior VP of Business Development", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Subra  Sankar Ph.D.", "age": 63, "title": "Senior Vice President of Product Development", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 38473, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.48, "open": 2.49, "dayLow": 2.47, "dayHigh": 2.5708, "regularMarketPreviousClose": 2.48, "regularMarketOpen": 2.49, "regularMarketDayLow": 2.47, "regularMarketDayHigh": 2.5708, "beta": 1.018, "forwardPE": -3.1728394, "volume": 56872, "regularMarketVolume": 56872, "averageVolume": 71009, "averageVolume10days": 57420, "averageDailyVolume10Day": 57420, "bid": 2.54, "ask": 2.6, "bidSize": 100, "askSize": 100, "marketCap": 332704480, "fiftyTwoWeekLow": 2.19, "fiftyTwoWeekHigh": 4.0, "fiftyDayAverage": 2.4741, "twoHundredDayAverage": 2.71035, "currency": "USD", "enterpriseValue": 176178896, "floatShares": 41794553, "sharesOutstanding": 125411000, "sharesShort": 1188362, "sharesShortPriorMonth": 1171467, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0095, "heldPercentInsiders": 0.33505002, "heldPercentInstitutions": 0.50126, "shortRatio": 16.6, "shortPercentOfFloat": 0.028499998, "bookValue": 1.876, "priceToBook": 1.369936, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -69642000, "trailingEps": -0.55, "forwardEps": -0.81, "enterpriseToEbitda": -2.218, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "NAUT", "underlyingSymbol": "NAUT", "shortName": "Nautilus Biotechnology, Inc.", "longName": "Nautilus Biotechnology, Inc.", "firstTradeDateEpochUtc": 1596807000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "74c8843b-ea34-3da1-9692-7e83386da8d7", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.57, "targetHighPrice": 6.0, "targetLowPrice": 2.5, "targetMeanPrice": 4.13, "targetMedianPrice": 4.0, "recommendationMean": 2.4, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 167443008, "totalCashPerShare": 1.335, "ebitda": -79421000, "totalDebt": 32602000, "quickRatio": 19.288, "currentRatio": 19.69, "debtToEquity": 13.857, "returnOnAssets": -0.16875, "returnOnEquity": -0.26533002, "freeCashflow": -34382000, "operatingCashflow": -57361000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]